Mohsen Saidinejad: Clinical Trials

1 trial sponsored by Mohsen Saidinejad, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Mohsen Saidinejad: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
Sub-dissociative Ketamine Infusion, Normal Saline Placebo Infusion - Sickle Cell Disease, Vaso-Occlusive Pain Episode in Sickle Cell Disease
Phase 2RecruitingMohsen Saidinejad1202026-09-102026-09-02

Conditions studied

Agnosia (1)  ·  Anemia, Sickle Cell (1)  ·  Vaso-Occlusive Crises (1)

Countries

United States (1)